Weight loss technology for people with treated type 2 diabetes

a randomized controlled trial

Kuat Oshakbayev, Bibazhar Dukenbayeva, Gulnar Togizbayeva, Aigul Durmanova, Meruyert Gazaliyeva, Abdul Sabir, Aliya Issa, Alisher Idrisov

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The prevalence of type 2 diabetes is increasing in worldwide despite the development of new treatment methods. Aim of the study was to evaluate a weight loss method on body composition, glycemic, lipid and hormone profiles, blood pressure and reactive oxygen species in people with treated type 2 diabetes. Methods: A 24-week open, prospective, randomized, controlled clinical trial including 272 adult patients with treated type 2 diabetes was performed. The patients were divided in two groups: Main group consisted of 208 patients who followed a method including a calorie restriction diet and optimal physical activity; Control included 64 patients who received conventional drug treatment with weight loss. Main Outcome Measures were weight loss, fasting glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c. Secondary endpoints were blood pressure, lipid and insulin blood levels. Results: At 24 weeks, patients in Main weight lost between 8-18 kg (10-21%); their body mass index significantly decreased (-4.2 kg/m2) as well as their waist circumference (-13 cm) compared to Control. In Main weight loss was achieved fatty mass reduction. In Main fasting glucose and OGTT, HbA1c, blood pressure, reactive oxygen species decreased significantly, whereas hemoglobin levels and heel bone mineral density increased. In Main blood insulin levels decreased by 72.0%, cortisol levels decreased by 40.7%, while testosterone levels in men increased by 2.4 times from baseline. The application of the weight loss method led to a decrease in drug doses leading to their complete withdrawal. Conclusions: The results of this study show the beneficial role of a weight loss method in improving glycemic, lipid and hormone profiles, electrolyte and biochemical indices, blood pressure, reactive oxygen species and bone mineral density in patients with treated type 2 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT02503865 . Retrospectively registered November 2015.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalNutrition and Metabolism
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 31 2017
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Weight Loss
Randomized Controlled Trials
Technology
Blood Pressure
Reactive Oxygen Species
Glucose Tolerance Test
Lipids
Bone Density
Fasting
Hormones
Insulin
Glucose
Calcaneus
Waist Circumference
Body Composition
Pharmaceutical Preparations
Electrolytes
Hydrocortisone
Testosterone

Keywords

  • Glycemic/lipid and hormone profiles
  • Lipid/protein oxidation
  • Restriction diet
  • Type 2 diabetes
  • Weight loss

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Oshakbayev, K., Dukenbayeva, B., Togizbayeva, G., Durmanova, A., Gazaliyeva, M., Sabir, A., ... Idrisov, A. (2017). Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial. Nutrition and Metabolism, 14(1), 1-9. https://doi.org/10.1186/s12986-017-0163-9

Weight loss technology for people with treated type 2 diabetes : a randomized controlled trial. / Oshakbayev, Kuat; Dukenbayeva, Bibazhar; Togizbayeva, Gulnar; Durmanova, Aigul; Gazaliyeva, Meruyert; Sabir, Abdul; Issa, Aliya; Idrisov, Alisher.

In: Nutrition and Metabolism, Vol. 14, No. 1, 31.01.2017, p. 1-9.

Research output: Contribution to journalArticle

Oshakbayev, K, Dukenbayeva, B, Togizbayeva, G, Durmanova, A, Gazaliyeva, M, Sabir, A, Issa, A & Idrisov, A 2017, 'Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial', Nutrition and Metabolism, vol. 14, no. 1, pp. 1-9. https://doi.org/10.1186/s12986-017-0163-9
Oshakbayev K, Dukenbayeva B, Togizbayeva G, Durmanova A, Gazaliyeva M, Sabir A et al. Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial. Nutrition and Metabolism. 2017 Jan 31;14(1):1-9. https://doi.org/10.1186/s12986-017-0163-9
Oshakbayev, Kuat ; Dukenbayeva, Bibazhar ; Togizbayeva, Gulnar ; Durmanova, Aigul ; Gazaliyeva, Meruyert ; Sabir, Abdul ; Issa, Aliya ; Idrisov, Alisher. / Weight loss technology for people with treated type 2 diabetes : a randomized controlled trial. In: Nutrition and Metabolism. 2017 ; Vol. 14, No. 1. pp. 1-9.
@article{18391c64e8eb4a9b9f7a0b9e465c9cc3,
title = "Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial",
abstract = "Background: The prevalence of type 2 diabetes is increasing in worldwide despite the development of new treatment methods. Aim of the study was to evaluate a weight loss method on body composition, glycemic, lipid and hormone profiles, blood pressure and reactive oxygen species in people with treated type 2 diabetes. Methods: A 24-week open, prospective, randomized, controlled clinical trial including 272 adult patients with treated type 2 diabetes was performed. The patients were divided in two groups: Main group consisted of 208 patients who followed a method including a calorie restriction diet and optimal physical activity; Control included 64 patients who received conventional drug treatment with weight loss. Main Outcome Measures were weight loss, fasting glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c. Secondary endpoints were blood pressure, lipid and insulin blood levels. Results: At 24 weeks, patients in Main weight lost between 8-18 kg (10-21{\%}); their body mass index significantly decreased (-4.2 kg/m2) as well as their waist circumference (-13 cm) compared to Control. In Main weight loss was achieved fatty mass reduction. In Main fasting glucose and OGTT, HbA1c, blood pressure, reactive oxygen species decreased significantly, whereas hemoglobin levels and heel bone mineral density increased. In Main blood insulin levels decreased by 72.0{\%}, cortisol levels decreased by 40.7{\%}, while testosterone levels in men increased by 2.4 times from baseline. The application of the weight loss method led to a decrease in drug doses leading to their complete withdrawal. Conclusions: The results of this study show the beneficial role of a weight loss method in improving glycemic, lipid and hormone profiles, electrolyte and biochemical indices, blood pressure, reactive oxygen species and bone mineral density in patients with treated type 2 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT02503865 . Retrospectively registered November 2015.",
keywords = "Glycemic/lipid and hormone profiles, Lipid/protein oxidation, Restriction diet, Type 2 diabetes, Weight loss",
author = "Kuat Oshakbayev and Bibazhar Dukenbayeva and Gulnar Togizbayeva and Aigul Durmanova and Meruyert Gazaliyeva and Abdul Sabir and Aliya Issa and Alisher Idrisov",
year = "2017",
month = "1",
day = "31",
doi = "10.1186/s12986-017-0163-9",
language = "English",
volume = "14",
pages = "1--9",
journal = "Nutrition and Metabolism",
issn = "1743-7075",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Weight loss technology for people with treated type 2 diabetes

T2 - a randomized controlled trial

AU - Oshakbayev, Kuat

AU - Dukenbayeva, Bibazhar

AU - Togizbayeva, Gulnar

AU - Durmanova, Aigul

AU - Gazaliyeva, Meruyert

AU - Sabir, Abdul

AU - Issa, Aliya

AU - Idrisov, Alisher

PY - 2017/1/31

Y1 - 2017/1/31

N2 - Background: The prevalence of type 2 diabetes is increasing in worldwide despite the development of new treatment methods. Aim of the study was to evaluate a weight loss method on body composition, glycemic, lipid and hormone profiles, blood pressure and reactive oxygen species in people with treated type 2 diabetes. Methods: A 24-week open, prospective, randomized, controlled clinical trial including 272 adult patients with treated type 2 diabetes was performed. The patients were divided in two groups: Main group consisted of 208 patients who followed a method including a calorie restriction diet and optimal physical activity; Control included 64 patients who received conventional drug treatment with weight loss. Main Outcome Measures were weight loss, fasting glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c. Secondary endpoints were blood pressure, lipid and insulin blood levels. Results: At 24 weeks, patients in Main weight lost between 8-18 kg (10-21%); their body mass index significantly decreased (-4.2 kg/m2) as well as their waist circumference (-13 cm) compared to Control. In Main weight loss was achieved fatty mass reduction. In Main fasting glucose and OGTT, HbA1c, blood pressure, reactive oxygen species decreased significantly, whereas hemoglobin levels and heel bone mineral density increased. In Main blood insulin levels decreased by 72.0%, cortisol levels decreased by 40.7%, while testosterone levels in men increased by 2.4 times from baseline. The application of the weight loss method led to a decrease in drug doses leading to their complete withdrawal. Conclusions: The results of this study show the beneficial role of a weight loss method in improving glycemic, lipid and hormone profiles, electrolyte and biochemical indices, blood pressure, reactive oxygen species and bone mineral density in patients with treated type 2 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT02503865 . Retrospectively registered November 2015.

AB - Background: The prevalence of type 2 diabetes is increasing in worldwide despite the development of new treatment methods. Aim of the study was to evaluate a weight loss method on body composition, glycemic, lipid and hormone profiles, blood pressure and reactive oxygen species in people with treated type 2 diabetes. Methods: A 24-week open, prospective, randomized, controlled clinical trial including 272 adult patients with treated type 2 diabetes was performed. The patients were divided in two groups: Main group consisted of 208 patients who followed a method including a calorie restriction diet and optimal physical activity; Control included 64 patients who received conventional drug treatment with weight loss. Main Outcome Measures were weight loss, fasting glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c. Secondary endpoints were blood pressure, lipid and insulin blood levels. Results: At 24 weeks, patients in Main weight lost between 8-18 kg (10-21%); their body mass index significantly decreased (-4.2 kg/m2) as well as their waist circumference (-13 cm) compared to Control. In Main weight loss was achieved fatty mass reduction. In Main fasting glucose and OGTT, HbA1c, blood pressure, reactive oxygen species decreased significantly, whereas hemoglobin levels and heel bone mineral density increased. In Main blood insulin levels decreased by 72.0%, cortisol levels decreased by 40.7%, while testosterone levels in men increased by 2.4 times from baseline. The application of the weight loss method led to a decrease in drug doses leading to their complete withdrawal. Conclusions: The results of this study show the beneficial role of a weight loss method in improving glycemic, lipid and hormone profiles, electrolyte and biochemical indices, blood pressure, reactive oxygen species and bone mineral density in patients with treated type 2 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT02503865 . Retrospectively registered November 2015.

KW - Glycemic/lipid and hormone profiles

KW - Lipid/protein oxidation

KW - Restriction diet

KW - Type 2 diabetes

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=85011411560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011411560&partnerID=8YFLogxK

U2 - 10.1186/s12986-017-0163-9

DO - 10.1186/s12986-017-0163-9

M3 - Article

VL - 14

SP - 1

EP - 9

JO - Nutrition and Metabolism

JF - Nutrition and Metabolism

SN - 1743-7075

IS - 1

ER -